Company Filing History:
Years Active: 2003-2009
Title: The Innovative Contributions of Allan Draisey
Introduction
Allan Draisey is a notable inventor based in Felpham, GB. He has made significant contributions to the field of pharmaceuticals through his innovative designs and methods. With a total of 4 patents to his name, Draisey has focused on developing advanced capsule technologies that enhance the delivery of medications.
Latest Patents
Draisey's latest patents include a method and apparatus for making capsules. This invention involves producing capsules from two films of a water-soluble polymeric material. The process includes deforming the films to create multiple recesses, which are then filled using adjacent rotary dies. These dies not only shape the capsules but also act as electrodes for welding the films together through dielectric welding. The resulting capsules can be separated from the web by various methods, ensuring efficient production. Another patent focuses on producing capsules from at least three films of a similar polymeric material, which are filled and welded together to form filled capsules. The materials used may include gelatin or water-soluble cellulose derivatives, providing versatility in capsule production.
Career Highlights
Throughout his career, Draisey has worked with several companies, including Stanelco Fibre Optics Ltd. and Ingel Technologies Ltd. His experience in these organizations has contributed to his expertise in the field of innovative pharmaceutical delivery systems.
Collaborations
Draisey has collaborated with notable coworkers such as Ryan Grimes and David John Smith. Their combined efforts have likely fostered a creative environment that has led to the development of groundbreaking technologies.
Conclusion
Allan Draisey's contributions to the field of pharmaceuticals through his innovative capsule technologies demonstrate his commitment to improving medication delivery systems. His patents reflect a deep understanding of materials and processes that enhance the efficacy of pharmaceutical products.